QURE uniQure N.V.

NASDAQ
$44.93

uniQure N.V. (QURE) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with QURE's own trailing one-year pace, with 94% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
11
38 transactions
Purchases
$0
0 shares
Sales
$17.9M
433,229 shares
Net activity
-$17.9M
purchases less sales

How much of that selling was preplanned? 94% planned / 6% discretionary

10b5-1 plan sales $16.9M 28 transactions · 395,938 shares
Discretionary sales $1.0M 10 transactions · 37,291 shares

Largest single sale: $2.5M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Kapusta Matthew C 3 fills CEO, Managing Director Sell 10b5-1 21,082 $45.16 $952.1K 531,109 −3.8% of holding
Abi-Saab Walid 2 fills Chief Medical Officer Sell 10b5-1 30,000 $46.42 $1.4M 168,235 −15.1% of holding
Kaye Jack 2 fills Director Sell 10b5-1 21,167 $46.44 $983.0K 25,996 −44.9% of holding
Abi-Saab Walid Chief Medical Officer Sell 1,434 $46.86 $67.2K 168,235 −0.8% of holding
Kapusta Matthew C CEO, Managing Director Sell 10b5-1 28,716 $50.02 $1.4M 519,227 −5.2% of holding
Kapusta Matthew C CEO, Managing Director Sell 10b5-1 6,696 $50.00 $334.8K 519,227 −1.3% of holding
Kapusta Matthew C 2 fills CEO, Managing Director Sell 10b5-1 41,671 $50.00 $2.1M 558,810 −6.9% of holding
Kapusta Matthew C 6 fills CEO, Managing Director Sell 10b5-1 164,429 $44.32 $7.3M 699,262 −19% of holding
Balachandran Madhavan 3 fills Director Sell 10b5-1 11,685 $45.06 $526.5K 49,644 −19.1% of holding
Kaye Jack Director Sell 10b5-1 5,295 $42.57 $225.4K 25,996 −16.9% of holding
Balachandran Madhavan Director Sell 10b5-1 10,000 $27.85 $278.5K 43,254 −18.8% of holding
Potts Jeannette Chief Legal Officer Sell 5,237 $27.67 $144.9K 133,246 −3.8% of holding
O'Keefe Kylie Chief Customer & Strat Officer Sell 15,936 $27.06 $431.2K 108,864 −12.8% of holding
Gut Robert Director Sell 2,726 $27.06 $73.8K 32,259 −7.8% of holding
Springhorn Jeremy P. Director Sell 1,993 $27.06 $53.9K 43,251 −4.4% of holding
Jacques Rachelle Suzanne Director Sell 1,993 $27.06 $53.9K 33,903 −5.6% of holding
POST LEONARD E Director Sell 1,993 $27.06 $53.9K 35,494 −5.3% of holding
Kaye Jack Director Sell 1,993 $27.06 $53.9K 25,996 −7.1% of holding
Meek David D. Director Sell 1,993 $27.06 $53.9K 39,747 −4.8% of holding
Balachandran Madhavan Director Sell 1,993 $27.06 $53.9K 43,254 −4.4% of holding
Gut Robert 3 fills Director Sell 10b5-1 7,552 $26.05 $196.7K 32,342 −18.9% of holding
Kaye Jack Director Sell 10b5-1 2,645 $30.01 $79.4K 20,439 −11.5% of holding
Abi-Saab Walid 2 fills Chief Medical Officer Sell 10b5-1 45,000 $25.06 $1.1M 189,669 −19.2% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.